Literature DB >> 25380223

Leading a Horse to Water: Facilitating Registration and Use of a Prescription Drug Monitoring Program.

Richard A Deyo1,2,3,4, Jessica M Irvine4, Sara E Hallvik4, Christi Hildebran4, Todd Beran5, Lisa M Millet5, Miguel Marino1,3.   

Abstract

OBJECTIVES: Prescription Drug Monitoring Programs (PDMPs) can help inform patient management, coordinate care, and identify drug safety risks, abuse, or diversion. However, many clinicians are not registered to use these systems, and use may be suboptimal. We sought to describe outreach efforts in 1 state (Oregon); quantify uptake of system use; identify barriers; and identify potential system improvements.
METHODS: Program reports of outreach efforts and operational metrics provided rates of registration and use. A statewide survey identified perceived barriers and potential improvements from users and nonusers of the system.
RESULTS: Even with extensive registration efforts, <25% of clinicians and pharmacists acquired PDMP accounts over 2 years of operation. Rapid increases in registration and use in 2013 corresponded to new requirements among large pharmacy chains that pharmacists register for and use the PDMP. Among surveyed PDMP nonusers, nearly half were unaware that they could register. Among users and nonusers, over two thirds indicated that time constraints were a major barrier and over half thought that inability to delegate access was a major barrier. Desired improvements included linking state systems, faster entry of pharmacy data, and use of unique patient identifiers. Users also wanted better insurance coverage for mental health and addiction referrals. DISCUSSION: Increasing registration and use of PDMPs remains important. Clinician feedback indicates that program enhancements and health care system changes would facilitate using and responding to PDMP information. It appears premature to judge the efficacy of PDMPs until best practices for their use are identified and impacts are assessed.

Entities:  

Year:  2015        PMID: 25380223      PMCID: PMC4424191          DOI: 10.1097/AJP.0000000000000180

Source DB:  PubMed          Journal:  Clin J Pain        ISSN: 0749-8047            Impact factor:   3.442


  13 in total

1.  Reported response rates to mailed physician questionnaires.

Authors:  S M Cummings; L A Savitz; T R Konrad
Journal:  Health Serv Res       Date:  2001-02       Impact factor: 3.402

2.  Awareness and utilization of a prescription monitoring program among physicians.

Authors:  Lance Feldman; Kristi Skeel Williams; John Coates; Michele Knox
Journal:  J Pain Palliat Care Pharmacother       Date:  2011-09-21

3.  Medication reconciliation for controlled substances--an "ideal" prescription-drug monitoring program.

Authors:  Jeanmarie Perrone; Lewis S Nelson
Journal:  N Engl J Med       Date:  2012-05-30       Impact factor: 91.245

4.  Prescribing practices, knowledge, and use of prescription drug monitoring programs (PDMP) by a national sample of medical toxicologists, 2012.

Authors:  Jeanmarie Perrone; Francis J DeRoos; Lewis S Nelson
Journal:  J Med Toxicol       Date:  2012-12

5.  Pain management by primary care physicians, pain physicians, chiropractors, and acupuncturists: a national survey.

Authors:  Brenda Breuer; Ricardo Cruciani; Russell K Portenoy
Journal:  South Med J       Date:  2010-08       Impact factor: 0.954

6.  How does use of a prescription monitoring program change medical practice?

Authors:  Traci C Green; Marita R Mann; Sarah E Bowman; Nickolas Zaller; Xaviel Soto; John Gadea; Catherine Cordy; Patrick Kelly; Peter D Friedmann
Journal:  Pain Med       Date:  2012-07-30       Impact factor: 3.750

7.  Prescribers and pharmacists requests for prescription monitoring program (PMP) data: does PMP structure matter?

Authors:  Marc L Fleming; Hitesh Chandwani; Jamie C Barner; Stephanie N Weber; Tony T Okoro
Journal:  J Pain Palliat Care Pharmacother       Date:  2013-05-20

8.  Who uses a prescription drug monitoring program and how? Insights from a statewide survey of Oregon clinicians.

Authors:  Jessica M Irvine; Sara E Hallvik; Christi Hildebran; Miguel Marino; Todd Beran; Richard A Deyo
Journal:  J Pain       Date:  2014-04-29       Impact factor: 5.820

9.  Prescription drug monitoring programs and death rates from drug overdose.

Authors:  Leonard J Paulozzi; Edwin M Kilbourne; Hema A Desai
Journal:  Pain Med       Date:  2011-02-18       Impact factor: 3.750

10.  Measures such as interstate cooperation would improve the efficacy of programs to track controlled drug prescriptions.

Authors:  Richard A Deyo; Jessica M Irvine; Lisa M Millet; Todd Beran; Nicole O'Kane; Dagan A Wright; Dennis McCarty
Journal:  Health Aff (Millwood)       Date:  2013-02-13       Impact factor: 6.301

View more
  18 in total

1.  Factors Influencing Judgments to Consult Prescription Monitoring Programs: A Factorial Survey Experiment.

Authors:  Matthew J Witry; Barbara J St Marie; Brahmendra Reddy Viyyuri; Paul D Windschitl
Journal:  Pain Manag Nurs       Date:  2019-05-24       Impact factor: 1.929

2.  Dental opioid prescribing and multiple opioid prescriptions among dental patients: Administrative data from the South Carolina prescription drug monitoring program.

Authors:  Jenna L McCauley; J Madison Hyer; V Ramesh Ramakrishnan; Renata Leite; Cathy L Melvin; Roger B Fillingim; Christie Frick; Kathleen T Brady
Journal:  J Am Dent Assoc       Date:  2016-04-05       Impact factor: 3.634

3.  Systematic Literature Review of Prescription Drug Monitoring Programs.

Authors:  Aditya Ponnapalli; Adela Grando; Anita Murcko; Pete Wertheim
Journal:  AMIA Annu Symp Proc       Date:  2018-12-05

4.  Association Between Initial Opioid Prescribing Patterns and Subsequent Long-Term Use Among Opioid-Naïve Patients: A Statewide Retrospective Cohort Study.

Authors:  Richard A Deyo; Sara E Hallvik; Christi Hildebran; Miguel Marino; Eve Dexter; Jessica M Irvine; Nicole O'Kane; Joshua Van Otterloo; Dagan A Wright; Gillian Leichtling; Lisa M Millet
Journal:  J Gen Intern Med       Date:  2016-08-02       Impact factor: 5.128

5.  Physician Time Burden Associated with Querying Prescription Drug Monitoring Programs.

Authors:  Marcus A Bachhuber; Brendan Saloner; Marc LaRochelle; Jessica S Merlin; Brandon C Maughan; Dan Polsky; Naum Shaparin; Sean M Murphy
Journal:  Pain Med       Date:  2018-10-01       Impact factor: 3.750

6.  Clinicians' Use of Prescription Drug Monitoring Programs in Clinical Practice and Decision-Making.

Authors:  Gillian J Leichtling; Jessica M Irvine; Christi Hildebran; Deborah J Cohen; Sara E Hallvik; Richard A Deyo
Journal:  Pain Med       Date:  2017-06-01       Impact factor: 3.750

7.  Advanced visualizations to interpret prescription drug monitoring program information.

Authors:  Scott G Weiner; Karen M Sherritt; Zoe Tseng; Jaya Tripathi
Journal:  Drug Alcohol Depend       Date:  2019-06-25       Impact factor: 4.492

8.  Opioid prescribing and risk mitigation implementation in the management of acute pain: Results from The National Dental Practice-Based Research Network.

Authors:  Jenna L McCauley; Renata S Leite; Valeria V Gordan; Roger B Fillingim; Gregg H Gilbert; Cyril Meyerowitz; David Cochran; D Brad Rindal; Kathleen T Brady
Journal:  J Am Dent Assoc       Date:  2018-03-15       Impact factor: 3.634

9.  Association of Prescription Drug Monitoring Program Use With Opioid Prescribing and Health Outcomes: A Comparison of Program Users and Nonusers.

Authors:  Richard A Deyo; Sara E Hallvik; Christi Hildebran; Miguel Marino; Rachel Springer; Jessica M Irvine; Nicole O'Kane; Joshua Van Otterloo; Dagan A Wright; Gillian Leichtling; Lisa M Millet; Jody Carson; Wayne Wakeland; Dennis McCarty
Journal:  J Pain       Date:  2017-10-18       Impact factor: 5.820

10.  Dental opioid prescribing practices and risk mitigation strategy implementation: Identification of potential targets for provider-level intervention.

Authors:  Jenna L McCauley; Renata S Leite; Cathy L Melvin; Roger B Fillingim; Kathleen T Brady
Journal:  Subst Abus       Date:  2015-12-16       Impact factor: 3.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.